SpectraScience: Innovations in Cancer Detection
SpectraScience has developed patented platform technology that diagnoses colorectal cancer, which has a market size of $1, 442.6 million.
biopsy
TargetScan Touch Proven Effective in Duke Study
A study published in Technology in Cancer Research and Treatment shows that Envisioneering Medical’s TargetScan Touch system is more effective in detecting prostate cancer than traditional biopsy methods.
Electro-Optical Announces MelaFind Study Results
Electro-Optical Sciences has announced positive results in a clinical trial of the MelaFind System, a handheld imaging device that detects melanomas at an early stage.